Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;32(9):1195-201.
doi: 10.1002/hed.21315.

Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

Matthew R Clay  1 , Mark Tabor, John Henry Owen, Thomas E Carey, Carol R Bradford, Gregory T Wolf, Max S Wicha, Mark E Prince
Affiliations

Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase

Matthew R Clay et al. Head Neck. 2010 Sep.

Abstract

Background: In accord with the cancer stem cell (CSC) theory, only a small subset of cancer cells are capable of forming tumors. We previously reported that CD44 isolates tumorigenic cells from head and neck squamous cell cancer (HNSCC). Recent studies indicate that aldehyde dehydrogenase (ALDH) activity may represent a more specific marker of CSCs.

Methods: Six primary HNSCCs were collected. Cells with high and low ALDH activity (ALDH(high)/ALDH(low)) were isolated. ALDH(high) and ALDH(low) populations were implanted into NOD/SCID mice and monitored for tumor development.

Results: ALDH(high) cells represented a small percentage of the tumor cells (1% to 7.8%). ALDH(high) cells formed tumors from as few as 500 cells in 24/45 implantations, whereas only 3/37 implantations of ALDH(low) cells formed tumors.

Conclusions: ALDH(high) cells comprise a subpopulation cells in HNSCCs that are tumorigenic and capable of producing tumors at very low numbers. This finding indicates that ALDH activity on its own is a highly selective marker for CSCs in HNSCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HNSCC cells that have high levels of ALDH expression also express CD44 at high levels. A. HN79 sorted for ALDH expression. P6 represents cells with high levels of ALDH expression (ALDHhigh). B. Only HN79 cells with elevated ALDH levels (P6) have been sorted for CD44 expression. The cells in P10 represent the population of cells with high ALDH expression that also express CD44. Approximately 70% of the ALDH high cells are also CD44+.
Figure 2
Figure 2
ALDHhigh cells reproduce tumors that are histologically similar to the original tumor. A.) HN84 primary tumor (20×). B.) HN84 tumor resultant from ALDHhigh injection (20×).
Figure 3
Figure 3
ALDHhigh cells recreate the original tumor heterogeneity for ALDH expression and maintain the distribution of ALDH in cancer cells passaged in the animal model. A. Primary HN84 cancer cells inhibited with DEAB. B. Primary HN84 cancer cells sorted for ALDH expression, 11.1% of the cancer cells are ALDHhigh. C. Cancer cells derived from tumors grown in the animal model (passage 1) inhibited with DEAB. D. Cancer cells sorted for ALDH expression from tumor grown in the animal model from HN84 ALDHhigh exhibit the same heterogeneity for ALDH expression as the original tumor.
Figure 4
Figure 4
Proposed model for the cancer stem cell compartment in HNSCC.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jain S, Khuri FR, Shin DM. Prevention of head and neck cancer: current status and future prospects. Curr Probl Cancer. 2004;28(5):265–86. - PubMed
    1. Golub TR. Genome-wide views of cancer. N Engl J Med. 2001;344:601–602. - PubMed
    1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. - PubMed
    1. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer. 2003;3:895–902. - PubMed
    1. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004;23:7274–7282. - PubMed

Publication types